Epilepsy Research UK & Angelini Pharma: Innovations in Healthcare – Urgent Research Call

Closing Date: 16/05/2022

Funding for a study that will use large-scale NHS clinical data records to understand and predict important clinical outcomes in refractory epilepsy.

Epilepsy Research UK, formed in April 2007, is a national charity dedicated to funding independent research into epilepsy. The charity aims to support and promote basic and clinical scientific research into the causes, treatments and prevention of epilepsy by supporting the work of scientists and clinicians throughout the UK.

Epilepsy Research UK has partnered with Angelini Pharma to commission a study that will use large-scale NHS clinical data records to understand and predict important clinical outcomes in refractory epilepsy. The collaboration between the two funders and the successful applicant will support a pilot study that will underpin future development in this area and accelerate innovations in the treatment and care of people living with uncontrolled epilepsy.

Applications are invited for high-quality pilot study proposals to support a research project lasting a maximum of two years. Grant proposals will identify sources of clinical data that can be organised and used to characterise predictors of epilepsy to accelerate innovations in clinical interventions and pathways. Multidisciplinary proposals are encouraged, with an emphasis on the long-term sustainability of the dataset and with the potential for scalability.

Applications are welcomed for health data research that includes all of the following components:

  • Identification of relevant patient dataset(s) such as NHS electronic health records or existing cohorts.
  • Organisation, design, and manipulation of data using novel or existing health data research analytic tools or programmes, with emphasis on future sustainability and scalability as a data resource.
  • Characterisation of predictors of refractory epilepsy using predefined clinically relevant and important outcomes, with the aim of understanding and predicting refractory epilepsy and to accelerate innovations in the treatment and care of people living with uncontrolled epilepsy.

Studies are required to include an appropriate Patient and Public Involvement (PPI) component in the proposed research, through Epilepsy Research UK’s Shape Epilepsy Research Network, which should be costed into the proposal.

Applicants must consider the feasibility of their approach (R&D approvals, capacity to recruit, etc). The health data to arise from the funded project should be scalable and accessible for future research use.

It is anticipated that one award will be made.

Funding body Epilepsy Research UK (ERUK)
Maximum value £200,000
Reference ID S23653
Category Medical Research

Fund or call Fund